Skip to content

Stereotaxis STXS Work in process

Work in process at other companies

Abbott logo
AbbottABT
$994M+11.7%
Stryker logo
StrykerSYK
$435M+9.3%
ITG
Integer HoldingsITGR
$157.03M+16.9%
iRadimed logo
iRadimedIRMD
$564K
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's work in process?
Stereotaxis (STXS) reported work in process of $1.91M in Q1 2026.
How has Stereotaxis's work in process changed year-over-year?
Stereotaxis's work in process increased by 123.8% year-over-year, from $852K to $1.91M.
What is the long-term trend for Stereotaxis's work in process?
Over 5 years (2020 to 2025), Stereotaxis's work in process has grown at a 38.8% compound annual growth rate (CAGR), from $433.03K to $2.23M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.